1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Comparisons between patients who had favorable and unfavorable outcomes 3 months after recanalization
Patient Demographics % or Median (IQR) P Favorable Outcome (n = 22) Unfavorable Outcome (n = 13) Age (yr) 64 (61–69) 73 (65–77) .040 Male 90.9 84.6 .618 Medical history – – – Diabetes mellitus 22.7 15.4 .689 Hypertension 54.5 53.8 1.000 Hypercholesterolemia 27.3 30.8 1.000 Smoking 45.5 53.8 .733 Cardiac disease 18.2 7.7 .630 Prior stroke 9.1 30.8 .166 Preprocedural findings Time to hospital (min)a 180 (138–208) 180 (100–210) .851 Time to IA therapy (min)a 255 (200–279) 280 (180–360) .669 NIHSS score at admission 9 (8–14) 17 (13–18) .003 Modified Rankin Scale score 4 (3–4) 4 (4–4) .005 3 45.5 7.7 .027 4 54.5 69.2 .486 5 0.0 23.1 .044 Right-sided occlusion 27.3 69.2 .032 Tandem occlusion site – – .247b M1 63.6 84.6 .259 M2 22.7 0.0 .134 Distal ICA thrombus 13.6 15.4 1.000 Received IV rtPA 18.2 30.8 .433 Periprocedural findings Procedure duration (min) 90 (66–128) 95 (70–110) .891 Urokinase dose (×104 U) 10 (10–30) 20 (10–20) .648 TICI grade – – .006c IIa 9.1 53.8 .006 IIb 22.7 15.4 .689 III 68.2 30.8 .043 Complications 0.0 15.4 .144 Symptomatic hemorrhage 0.0 7.7 .371 Brain swelling 0.0 7.7 .371 Follow-up evaluation at 3 months NIHSS scored 2 (2–4) 9 (6–16) <.001